DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL OF LOFEXIDINE VERSUS CLONIDINE IN THE TREATMENT OF HEROIN WITHDRAWAL
Saved in:
LIN, S.K., ET AL., DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL OF LOFEXIDINE VERSUS CLONIDINE IN THE TREATMENT OF HEROIN WITHDRAWAL. DRUG AND ALCOHOL DEPENDENCE, Vol. 48, no. 2 (1997), p. 127-133.
Ref.
63070
Location:
SIIS R.854
Palabras clave:
Ceguera, Drogodependencias, Fármacos, Heroína, Resultados, Síndrome de abstinencia, Tratamiento
Ceguera, Drogodependencias, Fármacos, Heroína, Resultados, Síndrome de abstinencia, Tratamiento
Similar Items: DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL OF LOFEXIDINE VERSUS CLONIDINE IN THE TREATMENT OF HEROIN WITHDRAWAL
- RANDOMISED DOUBLE-BLIND COMPARISON OF LOFEXIDINE AND CLONIDINE IN THE OUT-PATIENT TREATMENT OF OPIATE WITHDRAWAL
- RANDOMISED DOUBLE-BLIND COMPARISON OF LOFEXIDINE AND METHADONE IN THE IN-PATIENT TREATMENT OF OPIATE WITHDRAWAL
- DOUBLE-BLIND STUDY OF LOFEXIDINE AND CLONIDINE IN THE DETOXIFICATION OF OPIATE ADDICTS IN HOSPITAL
- A PHASE 3 PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTI-SITE TRIAL OF THE ALPHA-2-ADRENERGIC AGONIST, LOFEXIDINE, FOR OPIOID WITHDRAWAL
- THE EFFECTIVENESS OF COMBINED NALOXONE/LOFEXIDINE IN OPIATE DETOXIFICATION. RESULTS FROM A DOUBLE-BLIND RANDOMIZED AND PLACEBO-CONTROLLED TRIAL
- A META-ANALYSIS OF DOUBLE-BLIND PLACEBO-CONTROLLED TRIALS OF CLONIDINE FOR SMOKING CESSATION